gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · PAHCHealthcarePharmaceuticals

Phibro Animal Health Corporation Class A (PAHC)

$39.43+4.73%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$38.88▼ 10.35% in range
Nov 3, 2025Low $28.52 · High $59.58Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

Phibro Animal Health closed at $39.43 on Nov 4, up 4.73%, 33.8% below its 52-week closing high. Volume of 266.9K shares was 1.31× its 20-day average (above normal).

Split-adjusted performance: +7.7% over one month, -32.6% over six months, -9.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $396.75M, up 4.8% from a year earlier, with a net margin of 5.5%.

Short interest was 1.0M shares at the Oct 15 settlement, up 1.1% from the prior report (4.9% of float, 4.3 days to cover).

Market cap$1.60B40.6M shares
Revenue · quarter$396.7M+4.8% YoY
Diluted EPS$0.53+26.2% YoY
P/E · TTM16.1×P/S 1.1×
Net margin5.5%Gross 33.9%
Dividend yield1.22%$0.12 last paid
52-week range28.52 – 59.58−33.8% from high
Volume266.9K1.31× 20-day avg
Volatility · 60d31.5%Annualised
Short % of float4.9%4.3 days to cover
Net cash-$650.8MCash $82.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +4.1%1M +7.7%3M +11.1%6M −32.6%YTD +5.5%1Y −9.1%3Y +260.4%5Y +79.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum42
Revenue growth46
Net margin75
Value (low P/E)52
Size77

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short1.0M+1.1% vs prior
Days to cover4.3Settled Oct 15
% of float4.9%
Short vol. 10d54.8%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
PAHCPhibro Animal Health$39.43+4.73%−32.6%+4.8%5.5%16.1$1.60B
QUREuniQure$23.03−3.52%+0.9%+11.0%−1387.8%—$1.60BCompare
OCULOcular Therapeutix$7.14+4.69%−26.5%+0.1%−584.5%—$1.57BCompare
SUPNSupernus$28.21+0.21%−45.2%+18.0%9.2%—$1.64BCompare
ANIPANI Pharmaceuticals$71.65−0.87%−14.8%+25.9%8.6%16.5$1.65BCompare
KLRAKailera Therapeutics$12.80+1.75%————$1.66BCompare
NUVBNuvation Bio$4.73+0.85%−6.2%+555.6%−198.3%—$1.66BCompare
INVAInnoviva$21.26+1.58%−5.6%+19.3%−69.8%4.3$1.54BCompare
RAREUltragenyx Pharmaceutical$17.16+3.19%−33.8%+28.1%−43.0%—$1.69BCompare

News about Phibro Animal Health

All news →
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?Zacks Investment Research · Oct 28, 2026▲ PositiveWill Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · Oct 23, 2026▲ PositivePAHC or SYK: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 21, 2026▲ PositiveIs it the Right Time to Add Phibro Stock to Your Portfolio?Zacks Investment Research · Oct 8, 2026▲ PositivePAHC vs. HAE: Which Stock Should Value Investors Buy Now?Zacks Investment Research · Sep 18, 2026▲ Positive

Quick answers

What does Phibro Animal Health do?
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals.
What is PAHC's market cap?
$1.60B, based on the Nov 4 close of $39.43.
What is PAHC's P/E ratio?
16.1× trailing-twelve-month earnings of $99.72M.
Does Phibro Animal Health pay a dividend?
Yes. The latest regular dividend was $0.12 per share (ex-date Sep 2), an annualised yield of 1.22%.
How much of PAHC is sold short?
1.0M shares, 4.9% of float, as of Oct 15, 2026.
What sector is PAHC in?
Healthcare, in the Pharmaceuticals industry.

About Phibro Animal Health

Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.

HQ: Teaneck, NJ2,605 employeesListed Apr 11, 2014pahc.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology